CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
11 hedge funds and large institutions have $5.7M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
11
Holders Change
+2
Holders Change %
+22.22%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
LPL Financial
San Diego,
California
|
$477K |
2 |
2
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$540K |
3 |
3
Creative Planning
Overland Park,
Kansas
|
$0 |
4 |
4
Morgan Stanley
New York
|
$0 |